NIBP Validation Study

Description

The purpose of this study is to compare measurements of blood pressure (BP) between the Philips non-invasive blood pressure (NIBP) system (including NIBP cuff and portable patient monitor) and invasive radial arterial line (A-line) in critical care patients.

Conditions

Critical Illness

Talk to us

Study Overview

On this page

Study Details

Study overview

The purpose of this study is to compare measurements of blood pressure (BP) between the Philips non-invasive blood pressure (NIBP) system (including NIBP cuff and portable patient monitor) and invasive radial arterial line (A-line) in critical care patients.

Non-Invasive Blood Pressure Validation Study

NIBP Validation Study

Condition
Critical Illness
Intervention / Treatment

-

Contacts and Locations

Jacksonville

Mayo Clinic Jacksonville, Jacksonville, Florida, United States, 32224

Winston-Salem

Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States, 27157

Portland

Oregon Health & Science University, Portland, Oregon, United States, 97239

Charleston

Medical University of South Carolina, Charleston, South Carolina, United States, 29425

Salt Lake City

University of Utah, Salt Lake City, Utah, United States, 84112

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Patient admitted into the Neonatal Intensive Care Unit (NICU), Pediatric Intensive Care Unit (PICU), Intensive Care Unit (ICU), or Operating Room (OR)
  • * Adult aged 18 years and older, or parent/legal guardian of minor, willing and able to understand and provide informed consent/assent
  • * Indication for NIBP cuff
  • * Indication for radial arterial line
  • * Inability to place the study device appropriately due to patient's anatomy or condition
  • * Known pregnancy or lactating women (self-report)
  • * Patients treated with an intra-aortic balloon pump
  • * Aortic and mitral regurgitation (\> 2nd degree)
  • * Measurements taken in the lateral position
  • * Currently participating in another clinical trial with any product, treatment and/or medication that clinically interferes with the study endpoint(s)
  • * If valid SBP reference measurements for lateral difference is \> 15 mmHg
  • * If valid DBP reference measurements for lateral difference is \> 10 mmHg
  • * At the Principal Investigator's discretion, subject does not qualify to participate in the study for any reasons that are not mentioned above

Ages Eligible for Study

to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Philips Clinical & Medical Affairs Global,

Study Record Dates

2024-12-31